Functional Technologies Appoints Investment and Capital Markets Executive to Advisory Board

Functional Technologies Corp. (TSX VENTURE:FEB)(OTCQX:FEBTF) (the "Company") is
pleased to announce the appointment of Dr. Lincoln Rathnam to its Advisory
Board. Dr. Rathnam is an accomplished individual with a long and distinguished
background in the investment industry globally.


Dr. Rathnam's more than 30 years of founding, managing, strategic advisory and
transactional experience includes senior positions (i.e. Managing Director) at
Scudder, Stevens & Clark where he founded and managed the firm's high yield bond
and private equity departments, rose to the position of chairman of the stock
review committee, and also built Scudder's emerging markets fixed income assets
under management to approximately US$1.7 billion by the end of 1995. Dr. Rathnam
later held various management and/or senior advisory roles on investment roles,
including as Managing Director of BCP Securities Asia Pte Ltd., President of
Schooner Asset Management, partner at RHMK (USA), Inc. and Vistech Corporation,
and continues today to advise private and early stage public companies in
similar capacities. Prior to his career at Scudder, Stevens & Clark, he was an
equity analyst at CIGNA Investment Management. Dr. Rathnam holds a PhD from
Oxford University and a BA (Phi Beta Kappa) from Darmouth College. He is a
Chartered Financial Analyst, a former director of the Boston Security Analysts
Society, and is the author of numerous published articles on investing. 


"I am both pleased and proud to be associated with the important advances that
Functional Technologies has brought to consumer health and product quality,"
commented Dr. Rathnam. 


Howard Louie, Chief Business Development Officer of Functional Technologies,
stated "We are pleased that someone of Dr. Rathnam's extensive investment and
business acumen has agreed to join us as an Advisor to the Company at this
pivotal phase in the development of Functional Technologies, as we look forward
to building on the momentum and interest cultivated for our lead technologies,
our hydrogen sulphide-preventing and acrylamide-preventing yeast technologies
for the wine and food sectors, respectively."


The Board of Directors 

About Functional Technologies Corp. 

Functional Technologies develops and commercializes proprietary, advanced
yeast-based solutions to significant challenges in the food, beverage and
healthcare industries. The Company's platform improves the performance of innate
yeast functions, and prevents the formation of naturally occurring toxins and
contaminants that either affect final product quality or are classified by the
World Health Organization ("WHO") as probable human carcinogens. Functional
Technologies' lead technologies include yeasts that prevent and reduce the
formation of foul-smelling hydrogen sulphide (H2S) and the WHO classified
probable carcinogen, acrylamide - both by-products of food and beverage
processing. These contaminants are found in many commonly consumed items, such
as fermented food products and alcoholic beverages, and baked and fried foods.
For more information, please visit our website at www.functionaltechcorp.com.